VMS Invested Company New Horizon Health completed HK Main Board IPO

VMS Invested Company New Horizon Health completed HK Main Board IPO

 

We are pleased to announce that our invested company – New Horizon Health (6606.HK, “NHH”) has completed its Hong Kong Main Board IPO on 18th February 2021. Its public offering over-subscribed for over 4,000 times.

The IPO price of the Company was set at HKD 26.66 per share and has made a remarkable opening price on 18 February at HKD 76.0 per share with a 185.1% increment.

New Horizon Health is a leading Chinese molecular diagnostic company focusing on early cancer detection.

VMS led the Series C round financing of NHH in 2019 and participated in its Series D round financing in 2020.

If you would like to hear the latest updates on the Firm and the Fund, please feel free to contact our Investor Relations team at IR@VMSIG.COM.